1. Arjamaa, O. and Nikinmaa, M., Hypoxia regulates the natriuretic peptide system, Int. J. Physiol. Pathophysiol. Pharmacol., 2011, vol. 3, no. 3, pp. 191–201.
2. Bugrova, M.L., Yakovleva, E.I., and Abrosimov, D.A., The relationship of synthesis intensity, accumulation and secretion of natriuretic atrial peptide of cardiac myocytes with cardiac rhythm regulation in rats in early postperfusion period, STM, 2012, vol. 1, no. 3, pp. 26–30.
3. De Bold, A.J., Thirty years of research on atrial natriuretic factor: historical background and emerging concepts, Can. J. Pharmacol., 2011, vol. 89, pp. 527–531.
4. Hu, G., Huang, X., Zhang, K., Jiang, H., and Hu, X., Antiinflammatory effect of B-type natriuretic peptide postconditioning during myocardial ischemia-reperfusion: involvement of PI3K/Akt signaling pathway, Inflammation, 2014 (published online). doi: 10.1007/s1075301498950
5. Jarai, R., Kaun, C., Weiss, T.W., Speidl, W.S., Rychli, K., Maurer, G., Huber, K., and Wojta, J., Human cardiac fibroblasts express B-type natriuretic peptide: fluvastatin ameliorates its up-regulation by interleukin-1alpha, tumour necrosis factor-alpha and transforming growth factor-beta, J. Cell Mol. Med., 2009, vol. 13, pp. 4415–4421.